CORT vs. COST
Compare and contrast key facts about Corcept Therapeutics Incorporated (CORT) and Costco Wholesale Corporation (COST).
Scroll down to visually compare performance, riskiness, drawdowns, and other indicators and decide which better suits your portfolio: CORT or COST.
Correlation
The correlation between CORT and COST is 0.57, which is considered to be moderate. This suggests that the two assets have some degree of positive relationship in their price movements. Moderate correlation can be acceptable for portfolio diversification, offering a balance between risk and potential returns.
Performance
CORT vs. COST - Performance Comparison
Key characteristics
CORT:
1.50
COST:
1.50
CORT:
4.18
COST:
2.09
CORT:
1.57
COST:
1.28
CORT:
4.35
COST:
1.96
CORT:
12.52
COST:
5.76
CORT:
15.79%
COST:
5.88%
CORT:
122.13%
COST:
21.94%
CORT:
-94.28%
COST:
-53.39%
CORT:
-37.51%
COST:
-6.30%
Fundamentals
CORT:
$7.72B
COST:
$450.29B
CORT:
$1.23
COST:
$17.15
CORT:
59.16
COST:
59.18
CORT:
0.61
COST:
5.34
CORT:
11.62
COST:
1.71
CORT:
11.36
COST:
17.49
CORT:
$685.45M
COST:
$264.09B
CORT:
$674.70M
COST:
$35.11B
CORT:
$111.33M
COST:
$11.25B
Returns By Period
In the year-to-date period, CORT achieves a 41.66% return, which is significantly higher than COST's 10.24% return. Over the past 10 years, CORT has outperformed COST with an annualized return of 28.81%, while COST has yielded a comparatively lower 23.66% annualized return.
CORT
41.66%
1.26%
31.45%
181.02%
39.82%
28.81%
COST
10.24%
11.03%
10.53%
32.68%
29.14%
23.66%
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Risk-Adjusted Performance
CORT vs. COST — Risk-Adjusted Performance Rank
CORT
COST
CORT vs. COST - Risk-Adjusted Performance Comparison
This table presents a comparison of risk-adjusted performance metrics for Corcept Therapeutics Incorporated (CORT) and Costco Wholesale Corporation (COST). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Dividends
CORT vs. COST - Dividend Comparison
CORT has not paid dividends to shareholders, while COST's dividend yield for the trailing twelve months is around 0.47%.
| TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
CORT Corcept Therapeutics Incorporated | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
COST Costco Wholesale Corporation | 0.47% | 0.49% | 2.87% | 0.76% | 0.54% | 3.38% | 0.86% | 1.08% | 4.81% | 1.09% | 4.06% | 0.97% |
Drawdowns
CORT vs. COST - Drawdown Comparison
The maximum CORT drawdown since its inception was -94.28%, which is greater than COST's maximum drawdown of -53.39%. Use the drawdown chart below to compare losses from any high point for CORT and COST. For additional features, visit the drawdowns tool.
Volatility
CORT vs. COST - Volatility Comparison
Corcept Therapeutics Incorporated (CORT) has a higher volatility of 16.59% compared to Costco Wholesale Corporation (COST) at 8.28%. This indicates that CORT's price experiences larger fluctuations and is considered to be riskier than COST based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Financials
CORT vs. COST - Financials Comparison
This section allows you to compare key financial metrics between Corcept Therapeutics Incorporated and Costco Wholesale Corporation. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
CORT vs. COST - Profitability Comparison
CORT - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on May 2025, Corcept Therapeutics Incorporated reported a gross profit of 154.81M and revenue of 157.21M. Therefore, the gross margin over that period was 98.5%.
COST - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on May 2025, Costco Wholesale Corporation reported a gross profit of 9.61B and revenue of 63.72B. Therefore, the gross margin over that period was 15.1%.
CORT - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on May 2025, Corcept Therapeutics Incorporated reported an operating income of 3.42M and revenue of 157.21M, resulting in an operating margin of 2.2%.
COST - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on May 2025, Costco Wholesale Corporation reported an operating income of 2.32B and revenue of 63.72B, resulting in an operating margin of 3.6%.
CORT - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on May 2025, Corcept Therapeutics Incorporated reported a net income of 20.29M and revenue of 157.21M, resulting in a net margin of 12.9%.
COST - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on May 2025, Costco Wholesale Corporation reported a net income of 1.79B and revenue of 63.72B, resulting in a net margin of 2.8%.